MedTrace Logo

Vitreous Level Of Tumor Necrosis Factor Alpha In Patients With Retinal Vein Occlusion

NCT05532475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-11-27

No results posted yet for this study

Summary

To assess the levels of TNF- α in vitreous samples of patients with retinal vein occlusion prior to administration of intravitreal anti-VEGF and compare them to levels in vitreous samples of normal subjects so as to investigate the association of vitreous tumor necrosis factor with the pathogenesis of retinal vein occlusion.

Conditions

  • Retinal Vein Occlusion

Interventions

DIAGNOSTIC_TEST

measurement of vitreous level of tumor necrosis factor alpha

measurement of vitreous level of tumor necrosis factor alpha using ELISA technique

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-12
Primary Completion
2022-10-20
Completion
2022-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05532475 on ClinicalTrials.gov